Edith A. Perez - 22 Dec 2021 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role: Chief Medical Officer
Signature: /s/ William P. Quinn, Attorney-in-Fact
Issuer symbol: BOLT
Transactions as of: 22 Dec 2021
Net transactions value: +$117,174
Form type: 4
Filing time: 01 Feb 2022, 18:18:02 UTC
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BOLT	Common Stock	Purchase	$15,268	+917		$16.65^*	917	04 Jun 2021	Direct	F1
transaction	BOLT	Common Stock	Purchase	$1,907	+411	+45%	$4.64	1,328	06 Dec 2021	Direct	F1
transaction	BOLT	Common Stock	Options Exercise	$99,999	+35,714	+2689%	$2.80	37,042	22 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BOLT	Stock Option (Right to Buy)	Options Exercise	$0	-35,714	-16%	$0.000000	189,286	22 Dec 2021	Common Stock	35,714	$2.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F2	1/4th of the shares subject to the option shall vest on the one year anniversary of April 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider through each such date.